Stock Price Forecast

April 24, 2024


Forecasted Returns

7 Days Predict

30 Days Predict

90 Days Predict


Forecasted Market-Excess Returns

7 Days Predict

30 Days Predict

90 Days Predict

Loading CASTLE BIOSCIENCES INC chart...

About the Company

We do not have any company description for CASTLE BIOSCIENCES INC at the moment.

Exchange

Nasdaq

$98M

Total Revenue

441

Employees

$544M

Market Capitalization

-8.80

Price/Earning ratio

Fundamental Data and Insider Transactions (Quarterly data) Full Screen

Loading the fundamentals chart...

Latest $CSTL News

What Makes Castle Bioscience (CSTL) a Prospective Investment?

21d ago, source: InvestingChannel on MSN

The RiverPark/Next Century Growth Fund featured stocks like Castle Biosciences, Inc. (NASDAQ:CSTL) in the fourth quarter 2023 ...

Castle Biosciences Celebrates Esophageal Cancer Awareness Month through Advocacy and Educational Collaborations

15d ago, source: The Valdosta Daily Times

Castle Biosciences, Inc. (Nasdaq: CSTL), a company improving health through innovative tests that guide patient care, recognizes the importance of Esophageal Cancer Awareness Month and is providing ...

Castle Biosciences’ Chief Financial Officer Frank Stokes Recognized as a Top CFO of Houston for Second Consecutive Year

23y ago, source: The Valdosta Daily Times

“I am proud of Frank for earning a second placement among Houston’s Top 25 CFOs,” said Derek Maetzold, president and chief executive officer at Castle Biosciences. “In a city as dynamic and ...

Mobile-health Network Solutions prices $9M IPO at $4 per share

on MSN ago, source:

Mobile-health Network Solutions (MNDR) has priced its firm commitment IPO of 2.25 million shares at $4.00 per share. Read ...

Wall Street Analysts Are Bullish on Top Healthcare Picks

16d ago, source:

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Exagen (XGN – Research Report) and ...

Corero Network Security Enters New Relationship with TierPoint

15d ago, source: Le Lézard

Castle Biosciences, Inc. , a company improving health through innovative tests that guide patient care, today announced that it will release its financial results for the first quarter ended March 31, ...

TG Therapeutics: BRIUMVI Development Could Lead To Great Results

13d ago, source:

TG Therapeutics has strong barriers to entry and patent protection for BRIUMVI, allowing for potential growth in '24 and '25.

Analysts Offer Insights on Healthcare Companies: Pacific Biosciences (PACB) and Eli Lilly & Co (LLY)

7d ago, source:

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Pacific Biosciences (PACB – Research ...

MDXG: Legal Avenues

14d ago, source:

MDXG READ THE FULL MDXG RESEARCH REPORT Since the report of 2023 full year results on February 28th, MiMedx Group, Inc.

V Rising Ruins of Mortium Trailer Brings the Fight to Dracula

7d ago, source:

Stunlock Studios has released a new V Rising Ruins of Mortium trailer, which sees players taking the fight to the Prince of ...

V Rising ‘Ruins of Mortium’ gameplay trailer

7d ago, source: gematsu

Stunlock Studios has released a new gameplay trailer for vampire survival action RPG V Rising dubbed “Ruins of Mortium.” ...

V Rising - Official Legacy of Castlevania Gameplay Trailer | Triple-I Initiative Showcase

on MSN ago, source:

Legacy of Castlevania in this latest trailer for the upcoming crossover, which brings vampire hunter Simon Belmont to the ...

Latest Neutral (free) Forecasts

STRONG BUY BUY NEUTRAL SELL STRONG SELL ALL

Loading the latest forecasts...

My Portfolio

Loading your portfolio...